Fundz

Who to call at Ipsen and Foreseen Biotechnology, and when

Fundz watches for the moments Ipsen and Foreseen Biotechnology starts buying, and tells you who to reach.

  • An alert the day Ipsen and Foreseen Biotechnology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ipsen and Foreseen Biotechnology, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for FS001 antibody-drug conjugate

Jul 11, 2024

Contract Type

agreement

ParisBiotechnology

Description

Ipsen and Foreseen Biotechnology have announced an exclusive global licensing agreement for FS001, an antibody-drug conjugate (ADC) with first-in-class potential. FS001 targets a novel tumor-associated antigen with the potential to unlock critical new treatments for people living with hard-to-treat forms of cancer.

Company Information

Company

Ipsen and Foreseen Biotechnology

Location

Paris, Ile-de-France, France

About

Ipsen is a global biopharmaceutical group focused on innovation and specialty care. Foreseen Biotechnology is a biotechnology company with a focus on discovering and developing innovative therapeutic products.

Predictive Intelligence
Strategic

ML-powered predictions for Ipsen and Foreseen Biotechnology's next move

Learn about Strategic plan

Ipsen and Foreseen Biotechnology signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.